Fitusiran, an Investigational RNAi Therapeutic Targeting Antithrombin for the Treatment of Hemophilia: Updated Results from a Phase 1 and Phase 1/2 Extension Study in Patients without Inhibitors
暂无分享,去创建一个
A. Akinc | D. Bevan | K. Pasi | T. Lissitchkov | M. Ragni | C. Hay | S. Rangarajan | S. Austin | R. Kazmi | P. Chowdary | C. Soh | T. Mant | P. Georgiev | M. D. Creagh | I. Hegemann | C. Hay | A. Partisano | B. Sorenson